Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Evidence 104121
version: 12; Last updated: 2023-12-06 00:53:26+0000
Profiles: ComparativeEvidence, SingleStudyEvidence
url: https://fevir.net/resources/Evidence/104121
identifier: FEvIR Object Identifier/104121
name: ComparativeEvidence_Bypass_surgery_effects_on_Remission_of_diabetes_in_JAMA_2018_Norwegian_cohort_study
title: ComparativeEvidence: Bypass surgery effects on Remission of diabetes in JAMA 2018 Norwegian cohort study
status: Active
date: 2022-09-19 21:16:23+0000
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
author: Brian S. Alper:
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparativeEvidence |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | SingleStudyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: Derived From
Documents
Url https://jamanetwork.com/journals/jama/fullarticle/2669729
relatedArtifact
type: Cite As
citation:
ComparativeEvidence: Bypass surgery effects on Remission of diabetes in JAMA 2018 Norwegian cohort study [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 104121. Revised 2022-09-19. Available at: https://fevir.net/resources/Evidence/104121. Computable resource at: https://fevir.net/resources/Evidence/104121.
description:
greater likelihood of diabetes remission: AR, 57.5% vs 14.8%; RD, 42.7% [95% CI, 35.8%-49.7%], RR, 3.9 [95% CI, 2.8-5.4]
assertion:
Compared with specialized medical treatment, bariatric surgery appears to induce remission of diabetes.
variableDefinition
description:
Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included).
variableRole: Population
observed: StudyGroup: Severely Obese Adults 2018 Norwegian Cohort
variableDefinition
description:
bariatric surgery vs. specialized medical treatment without bariatric surgery
variableRole: Exposure
comparatorCategory: no bariatric surgery
intended: GroupAssignment: Bariatric Surgery vs. no bariatric surgery
variableDefinition
description:
Remission of diabetes
variableRole: Outcome
observed: OutcomeVariable: Remission of diabetes
synthesisType: not applicable
studyDesign: Observational research, Parallel cohort design, Longitudinal data collection
statistic
description:
Relative risk 3.9; 95% CI 2.8 to 5.4
note: Result observed without bariatric surgery was 14.8%, result observed with bariatric surgery was 57.5%
statisticType: Relative Risk
quantity: 3.9
SampleSizes
NumberOfStudies NumberOfParticipants KnownDataCount 1 1888 1888 AttributeEstimates
Description Type Level Range 95% CI 2.8 to 5.4
Confidence interval 0.95 2.8-5.4
| Description | Type | Rating |
rated down 2 levels due to observational study, rated up 1 level due to large effect size | Overall certainty | Moderate quality |
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-12-19
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change